恆指午後略破底後曾倒升逾340點 新經濟及中資金融股領漲
滬指及深成繼半日低收倒跌0.2%-0.7%後,午後在金融板塊發力推動,再度抽升0.9%及0.6%,報3,120及10,379。
已七連跌的恆指下午初段再次倒跌低見17,573再創近九個月低獲承接,在新經濟股及中資金融股推動,掉頭升破今早所創高位17,802,最多彈341點或1.9%高見17,965,現報17,840,反彈217點或1.2%,總成交額776億元。此外,恆生科技指數重越牛熊線,午後高見4,049,現報4,016,回升2.3%
藍籌股普遍反覆向好,中升(00881.HK)繼半日市逆內需股造好後,下午升幅曾擴至7.7%高見23.85元,現報23.6元,回升6.5%;濠賭股金沙(01928.HK)、銀娛(00027.HK)、攜程(09961.HK)、中芯(00981.HK)、聯想(00992.HK)及貼國際金價升的紫金(02899.HK)升逾2%-3%。然而,李寧(02331.HK)曾反覆低見36.65元,創近三年低,現報37.45元,逆市續跌2.7%;安踏(02020.HK)也反覆續跌0.9%曾低見76.5元創逾八個月低。
中資金融股午後發力,中國平安(02318.HK)、國壽(02628.HK)、建行(00939.HK)、招行(03968.HK)及工行(01398.HK)曾倒升逾1%-2%,後兩者跑贏曾分別高見31.05元及3.45元。友邦(01299.HK)午後曾漲2.4%至69.05元,現報68.5元,回升1.6%。
新經濟股方面,京東(09618.HK)、阿里(09988.HK)、美團(03690.HK)及網易(09999.HK)升2.1%-2.8%。今天放榜的百度(09888.HK)反覆升1.5%報123.8元。出口股創科(00669.HK)續升3%曾高見81.8元。
阿里健康(00241.HK)、藥明生物(02269.HK)及翰森(03692.HK)升逾2%-4%,後者跑贏股價曾高見10.1元(剛為10天線)。
碧桂園(02007.HK)及碧服(06098.HK)彈升逾2.5%,分別報0.76元及7.26元。然而,中海外(00688.HK)續跌逾1%曾低見15.14元創逾九個月低。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.